Correction to: Durvalumab: A Review in Extensive-Stage SCLC
Crossref DOI link: https://doi.org/10.1007/S11523-021-00863-W
Published Online: 2021-12-06
Published Print: 2022-01
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Al-Salama, Zaina T.
Text and Data Mining valid from 2021-12-06
Version of Record valid from 2021-12-06
Article History
First Online: 6 December 2021